600216 Stock Overview
Zhejiang Medicine Co., Ltd manufactures and sells life nutrition and pharmaceutical products in China.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
Zhejiang Medicine Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥9.76 |
| 52 Week High | CN¥11.90 |
| 52 Week Low | CN¥7.97 |
| Beta | -0.094 |
| 11 Month Change | -7.14% |
| 3 Month Change | 4.83% |
| 1 Year Change | -11.35% |
| 33 Year Change | -34.89% |
| 5 Year Change | -5.79% |
| Change since IPO | 251.29% |
Recent News & Updates
Zhejiang Medicine's (SHSE:600216) Earnings Are Weaker Than They Seem
May 02
Zhejiang Medicine (SHSE:600216) Has A Somewhat Strained Balance Sheet
Mar 29Shareholder Returns
| 600216 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 2.2% | -3.2% | -0.7% |
| 1Y | -11.4% | -11.4% | -14.6% |
Return vs Industry: 600216 matched the CN Pharmaceuticals industry which returned -11.4% over the past year.
Return vs Market: 600216 exceeded the CN Market which returned -14.6% over the past year.
Price Volatility
| 600216 volatility | |
|---|---|
| 600216 Average Weekly Movement | 4.9% |
| Pharmaceuticals Industry Average Movement | 5.4% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in CN Market | 10.1% |
| 10% least volatile stocks in CN Market | 4.1% |
Stable Share Price: 600216 has not had significant price volatility in the past 3 months.
Volatility Over Time: 600216's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 6,227 | Chun Lu | www.zmc.top |
Zhejiang Medicine Co., Ltd manufactures and sells life nutrition and pharmaceutical products in China. The company products include synthetic vitamin E, natural vitamin E, ß-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin. It also offers fat-soluble vitamins, retinoids, quinolone antibiotics, anti-resistance antibiotics, and other products, as well as animal nutrition products.
Zhejiang Medicine Co., Ltd. Fundamentals Summary
| 600216 fundamental statistics | |
|---|---|
| Market cap | CN¥9.38b |
| Earnings (TTM) | CN¥425.74m |
| Revenue (TTM) | CN¥8.04b |
22.0x
P/E Ratio1.2x
P/S RatioIs 600216 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600216 income statement (TTM) | |
|---|---|
| Revenue | CN¥8.04b |
| Cost of Revenue | CN¥5.57b |
| Gross Profit | CN¥2.46b |
| Other Expenses | CN¥2.04b |
| Earnings | CN¥425.74m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.44 |
| Gross Margin | 30.67% |
| Net Profit Margin | 5.30% |
| Debt/Equity Ratio | 8.5% |
How did 600216 perform over the long term?
See historical performance and comparison